Skip to main content
Fig. 1 | BMC Public Health

Fig. 1

From: A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development

Fig. 1

Flow diagram of screening process. *Reasons for exclusion: population size < 100; prevalence or seroprevalence based on a non-IgM or -IgG diagnostic method (eg, reverse transcriptase polymerase chain reaction); or data out of scope of review (incidence, infection rate, mortality, or long-term sequelae). CMV, cytomegalovirus; IgG, immunoglobulin G; IgM, immunoglobulin M; SLR, systematic literature review

Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us